A mobile health tool to help village doctors in Bangladesh manage pediatric diarrhea
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
This study is testing a new mobile app to help village doctors in Bangladesh better treat kids with diarrhea, which can be very serious, by giving them smart advice on when to use antibiotics and helping them improve their care.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10707328 on NIH RePORTER |
What this research studies
This research focuses on developing a mobile health application designed to assist village doctors in Bangladesh with the management of pediatric diarrhea, a leading cause of death in children. The application, known as the Accessible Diarrhea Etiology Prediction Tool (ADEPT), aims to provide clinical decision support to improve antibiotic stewardship and reduce the overuse of antimicrobials. By customizing an existing electronic clinical decision-support tool, the project will evaluate its effectiveness through a pilot study, ultimately aiming to enhance the knowledge and practices of rural healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are experiencing diarrhea and are treated by village doctors in Bangladesh.
Not a fit: Patients outside of the pediatric age range or those not receiving care from village doctors in rural Bangladesh may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce unnecessary antibiotic use and improve treatment outcomes for children suffering from diarrhea in rural Bangladesh.
How similar studies have performed: Previous research has shown success with mobile health tools in improving clinical practices in low- and middle-income countries, indicating a promising approach for this project.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Leung, Daniel Ted — University of Utah
- Study coordinator: Leung, Daniel Ted
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.